Works by Akay, Olga Meltem


Results: 71
    1
    2

    Which prognostic marker is responsible for the clinical heterogeneity in CLL with 13q deletion?

    Published in:
    Molecular Cytogenetics (17558166), 2021, v. 14, n. 1, p. 1, doi. 10.1186/s13039-020-00522-1
    By:
    • Durak Aras, Beyhan;
    • Isik, Sevgi;
    • Uskudar Teke, Hava;
    • Aslan, Abdulvahap;
    • Yavasoglu, Filiz;
    • Gulbas, Zafer;
    • Demirkan, Fatih;
    • Ozen, Hulya;
    • Cilingir, Oguz;
    • Inci, Nur Sena;
    • Gunden, Gulcin;
    • Bulduk, Tuba;
    • Erzurumluoglu Gokalp, Ebru;
    • Kocagil, Sinem;
    • Artan, Sevilhan;
    • Akay, Olga Meltem
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study.

    Published in:
    Geriatrics & Gerontology International, 2015, v. 15, n. 6, p. 729, doi. 10.1111/ggi.12341
    By:
    • Korkmaz, Serdal;
    • Dal, Mehmet Sinan;
    • Berber, Ilhami;
    • Sahin, Deniz Goren;
    • Dogu, Mehmet Hilmi;
    • Ayyildiz, Orhan;
    • Nizam, Ilknur;
    • Albayrak, Murat;
    • Esen, Ramazan;
    • Namdaroglu, Sinem;
    • Sencan, Mehmet;
    • Akay, Olga Meltem;
    • Hacioglu, Sibel;
    • Yildirim, Rahsan;
    • Eser, Ali;
    • Tombak, Anil;
    • Pala, Cigdem;
    • Ilhan, Osman
    Publication type:
    Article
    14
    15
    16

    P1073: A NEW SCORING SYSTEM TO PREDICT SURVIVAL IN ELDERLY ADVANCED STAGE HODGKIN LYMPHOMA PATIENTS: STUDY BY TURKISH SOCIETY OF HAEMATOLOGY LYMPHOMA ACADEMY WORKING GROUP.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971188.56679.1c
    By:
    • Mehtap, Özgür;
    • Toptas, Tayfur;
    • Sinan Dal, Mehmet;
    • Hayri Özsan, Güner;
    • Sayinalp, Nigün;
    • Saydam, Güray;
    • Ali Uçar, Mehmet;
    • Onur Kirgizlar, Hakki;
    • Salim, Ozan;
    • Tekinalp, Atakan;
    • Özkalemkaş, Fahir;
    • Pepedil Tanrikulu, Funda;
    • Meltem Akay, Olga;
    • Kiliçaslan, Emrah;
    • Paydas, Semra;
    • Civriz, Sinem;
    • Yilmaz, Mehmet;
    • Karakuş, Volkan;
    • Geçgel, Fatma;
    • Darçin, Tahir
    Publication type:
    Article
    17
    18
    19

    Brentuximab vedotin and bendamustine: an effective salvage therapy for relapsed or refractory Hodgkin lymphoma patients.

    Published in:
    Journal of Chemotherapy (Taylor & Francis Ltd), 2022, v. 34, n. 3, p. 190, doi. 10.1080/1120009X.2021.1976912
    By:
    • Uncu Ulu, Bahar;
    • Dal, Mehmet Sinan;
    • Yönal Hindilerden, İpek;
    • Akay, Olga Meltem;
    • Mehtap, Özgür;
    • Büyükkurt, Nurhilal;
    • Hindilerden, Fehmi;
    • Güneş, Ahmet Kürşad;
    • Yiğenoğlu, Tuğçe Nur;
    • Başcı, Semih;
    • Kızıl Çakar, Merih;
    • Yanardağ Açık, Didar;
    • Korkmaz, Serdal;
    • Ulaş, Turgay;
    • Özet, Gülsüm;
    • Ferhanoğlu, Burhan;
    • Nalçacı, Meliha;
    • Altuntaş, Fevzi
    Publication type:
    Article
    20
    21
    22

    Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 4, p. 663, doi. 10.1002/hon.3174
    By:
    • Birtas Atesoglu, Elif;
    • Gulbas, Zafer;
    • Uzay, Ant;
    • Ozcan, Muhit;
    • Ozkalemkas, Fahir;
    • Dal, Mehmet Sinan;
    • Kalyon, Hakan;
    • Akay, Olga Meltem;
    • Deveci, Burak;
    • Bekoz, Huseyin;
    • Sevindik, Omur Gokmen;
    • Toptas, Tayfur;
    • Yilmaz, Fergun;
    • Koyun, Derya;
    • Alkis, Nihan;
    • Alacacioglu, Inci;
    • Sonmez, Mehmet;
    • Yavasoglu, Irfan;
    • Tombak, Anil;
    • Mehtap, Ozgur
    Publication type:
    Article
    23

    Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 1, p. 97, doi. 10.1002/hon.3096
    By:
    • Vassilakopoulos, Theodoros P.;
    • Panitsas, Fotios;
    • Mellios, Zois;
    • Apostolidis, John;
    • Michael, Michalis;
    • Gurion, Ronit;
    • Ferhanoglu, Burhan;
    • Hatzimichael, Eleftheria;
    • Karakatsanis, Stamatios;
    • Dimou, Maria;
    • Kalpadakis, Christina;
    • Katodritou, Eirini;
    • Leonidopoulou, Theoni;
    • Kotsianidis, Ioannis;
    • Giatra, Hara;
    • Kanellias, Nick;
    • Sayyed, Ayman;
    • Tadmor, Tamar;
    • Akay, Olga Meltem;
    • Angelopoulou, Maria K.
    Publication type:
    Article
    24

    Brentuximab vedotin consolidation therapy after autologous stem‐cell transplantation in patients with high‐risk Hodgkin lymphoma: Multicenter retrospective study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 4, p. 498, doi. 10.1002/hon.2897
    By:
    • Akay, Olga Meltem;
    • Ozbalak, Murat;
    • Pehlivan, Mustafa;
    • Yildiz, Birol;
    • Uzay, Ant;
    • Yigenoglu, Tugce Nur;
    • Elverdi, Tugrul;
    • Kaynar, Leylagul;
    • Ayyildiz, Orhan;
    • Yonal Hindilerden, Ipek;
    • Goksoy, Hasan Sami;
    • Izmir Guner, Sebnem;
    • Gunes, Ahmet Kursad;
    • Sonmez, Mehmet;
    • Kurt Yuksel, Meltem;
    • Civriz Bozdag, Sinem;
    • Ozkurt, Zubeyde Nur;
    • Toptas, Tayfur;
    • Dogu, Mehmet Hilmi;
    • Salim, Ozan
    Publication type:
    Article
    25
    26
    27
    28

    Polatuzumab vedotin, rituximab, and bendamustine combination in relapsed or refractory diffuse large B-cell lymphoma: a real-world data from Turkey.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 1, p. 133, doi. 10.1007/s00277-022-05052-x
    By:
    • Dal, Mehmet Sinan;
    • Ulu, Bahar Uncu;
    • Uzay, Ant;
    • Akay, Olga Meltem;
    • Beşışık, Sevgi;
    • Yenerel, Mustafa Nuri;
    • Çelik, Serhat;
    • Kaynar, Leylagül;
    • Yücel, Orhan Kemal;
    • Deveci, Burak;
    • Sönmez, Mehmet;
    • Mehtap, Özgür;
    • Beköz, Hüseyin Saffet;
    • Sunu, Cenk;
    • Salim, Ozan;
    • Ulaş, Turgay;
    • Kartı, Sami;
    • Altuntaş, Fevzi;
    • Ferhanoğlu, Burhan;
    • Tuğlular, Tülin Fırat
    Publication type:
    Article
    29

    Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience.

    Published in:
    2021
    By:
    • Goren Sahin, Deniz;
    • Akay, Olga Meltem;
    • Keklik, Muzaffer;
    • Okan, Vahap;
    • Karakus, Abdullah;
    • Demir, Cengiz;
    • Erkurt, Mehmet Ali;
    • Ilkkilic, Kadir;
    • Yildirim, Rahsan;
    • Akgun Cagliyan, Gulsum;
    • Aksu, Salih;
    • Dogu, Mehmet Hilmi;
    • Dal, Mehmet Sinan;
    • Karakus, Volkan;
    • Gemici, Ali Ihsan;
    • Terzi, Hatice;
    • Kelkitli, Engin;
    • Sivgin, Serdar;
    • Unal, Ali;
    • Yilmaz, Mehmet
    Publication type:
    journal article
    30
    31
    32
    33
    34
    35
    36

    Effects of single-agent bortezomib as post-transplant consolidation therapy on multiple myeloma-related bone disease: a randomized phase II study.

    Published in:
    British Journal of Haematology, 2017, v. 178, n. 1, p. 61, doi. 10.1111/bjh.14637
    By:
    • Sezer, Orhan;
    • Beksac, Meral;
    • Hajek, Roman;
    • Sucak, Gülsan;
    • Cagirgan, Seckin;
    • Linkesch, Werner;
    • Meltem Akay, Olga;
    • Gülbas, Zafer;
    • Nahi, Hareth;
    • Plesner, Torben;
    • Snowden, John A.;
    • Timurağaoğlu, Ayşen;
    • Dechow, Tobias;
    • Lang, Alois;
    • Tuğlular, Tülin;
    • Drach, Johannes;
    • Armbrecht, Gabriele;
    • Potamianou, Anna;
    • Couturier, Catherine;
    • Olie, Robert A.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43

    P-125: An interim analysis of the Turkish Myeloma Registry among patients who have received up to two lines of therapy.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S102, doi. 10.1016/S2152-2650(21)02252-7
    By:
    • Sevindik, Omur Gokmen;
    • Özkurt, Zübeyde Nur;
    • Boga, Can;
    • Besisik, Sevgi Kalayoglu;
    • Ipek, Yildiz;
    • Gedük, Ayfer;
    • Harmandali, Aybüke;
    • Salihoglu, Ayse;
    • Sahin, Handan Haydaroglu;
    • Sönmez, Mehmet;
    • Vural, Filiz;
    • Akay, Olga Meltem;
    • Yüksel, Meltem Kurt;
    • Maral, Senem;
    • Ekinci, Ömer;
    • Kirkizlar, Hakki Onur;
    • Tekinalp, Atakan;
    • Demir, Nazli;
    • Merter, Mustafa;
    • Saydam, Güray
    Publication type:
    Article
    44

    HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S368, doi. 10.1016/S2152-2650(21)01845-0
    By:
    • Ozbalak, Murat;
    • Akay, Olga Meltem;
    • Pehlivan, Mustafa;
    • Yildiz, Birol;
    • Uzay, Ant;
    • Yigenoglu, Tugce Nur;
    • Elverdi, Tugrul;
    • Kaynar, Leylagul;
    • Ayyildiz.AUS-Dicle University Medical Faculty, Department ofInternal Medicine, Division of Hematology, Diyarbakir,Turkey, Orhan;
    • Hindilerden, Ipek Yonal;
    • Goksoy, Hasan Sami;
    • Guner, Sebnem Izmir;
    • Gunes, Ahmet Kursad;
    • Sonmez, Mehmet;
    • Yuksel, Meltem Kurt;
    • Bozdag, Sinem Civriz;
    • Ozkurt, Zubeyde Nur;
    • Toptas, Tayfur;
    • Dogu, Mehmet Hilmi;
    • Salim, Ozan
    Publication type:
    Article
    45

    Poster: HL-007: Brentuximab Vedotin Consolidation Therapy after Autologous Stem-Cell Transplantation in Patients with High-Risk Hodgkin Lymphoma: Multi-Center Retrospective Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01484-1
    By:
    • Ozbalak, Murat;
    • Akay, Olga Meltem;
    • Pehlivan, Mustafa;
    • Yildiz, Birol;
    • Uzay, Ant;
    • Yigenoglu, Tugce Nur;
    • Elverdi, Tugrul;
    • Kaynar, Leylagul;
    • Ayyildiz, Orhan;
    • Hindilerden, Ipek Yonal;
    • Goksoy, Hasan Sami;
    • Guner, Sebnem Izmir;
    • Gunes, Ahmet Kursad;
    • Sonmez, Mehmet;
    • Yuksel, Meltem Kurt;
    • Bozdag, Sinem Civriz;
    • Ozkurt, Zubeyde Nur;
    • Toptas, Tayfur;
    • Dogu, Mehmet Hilmi;
    • Salim, Ozan
    Publication type:
    Article
    46
    47
    48
    49

    Kimerik Antijen Reseptör-T-Hücre Tedavisi.

    Published in:
    Turkiye Klinikleri Journal of Internal Medicine / Türkiye Klinikleri İç Hastalıkları Dergisi, 2019, v. 4, n. 3, p. 139, doi. 10.5336/intermed.2019-65589
    By:
    • GÖREN ŞAHİN, Deniz;
    • AKAY, Olga Meltem
    Publication type:
    Article
    50